F-star
is an England-based biotechnology company that develops and commercializes novel antibody therapies for the treatment of cancer and orphan diseases... Read moreF-star
is an England-based biotechnology company that develops and commercializes novel antibody therapies for the treatment of cancer and orphan diseases... Read more
News
Apr 04, 2025
Endpoints News
F-star: F-star management takes company private, two years after $161M cash exit to Sino's invoX
Dec 28, 2024
Marketscreener
F-star: F-star Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Jul 04, 2024
Pharamceutical Technology
F-star: FS-222 by F-star Therapeutics for Ovarian Cancer: Likelihood of Approval
Feb 08, 2024
Pharamceutical Technology
F-star: FS-102 by F-star Therapeutics for Adenocarcinoma Of The Gastroesophageal Junction: Likelihood of Approval
Jul 06, 2023
Contract Pharma
F-star: Takeda, F-star Therapeutics Partner to Advance Immunotherapies
Jul 06, 2023
BioSpace
F-star: Takeda, F-star Sign Potential $1B Immuno-Oncology Agreement
Mar 23, 2023
ChinaBio Today
F-star: F-star Partners Second Early-Stage Tetravalent Bispecific Antibody with Takeda
Mar 09, 2023
MarketScreener
F-star: F star Therapeutics : Acquisition/Asset Disposal - Form 8-K
Mar 09, 2023
Pharmaceutical Business Review
F-star: invoX Pharma completes acquisition of F-star Therapeutics for $161m
Mar 07, 2023
MarketScreener
F-star: F-star Therapeutics Shares Rally After Cfius Clears Takeover
F-star Competitors
1
2
3
4
5
6
7
8
9
10